GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » 3-Year Revenue Growth Rate

Liaoning Chengda Biotechnology Co (SHSE:688739) 3-Year Revenue Growth Rate : -7.60% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co 3-Year Revenue Growth Rate?

Liaoning Chengda Biotechnology Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.90.

During the past 12 months, Liaoning Chengda Biotechnology Co's average Revenue per Share Growth Rate was -2.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -7.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Liaoning Chengda Biotechnology Co was 19.50% per year. The lowest was -7.60% per year. And the median was 12.75% per year.


Competitive Comparison of Liaoning Chengda Biotechnology Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's 3-Year Revenue Growth Rate falls into.



Liaoning Chengda Biotechnology Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Liaoning Chengda Biotechnology Co  (SHSE:688739) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Liaoning Chengda Biotechnology Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Liaoning Chengda Biotechnology Co (SHSE:688739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co (SHSE:688739) Headlines

No Headlines